- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Edotreotide.
Displaying page 1 of 1.
EudraCT Number: 2018-000398-64 | Sponsor Protocol Number: VHIO18001 | Start Date*: 2018-06-18 | |||||||||||
Sponsor Name:Vall d' Hebron Institute of Oncology (VHIO) | |||||||||||||
Full Title: Patterns of uptake of 18F-FDG and 68Ga-DOTA PET in advanced neuroendoctrine tumors | |||||||||||||
Medical condition: Gastroenteropancreatic neuroendocrine tumor disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001086-20 | Sponsor Protocol Number: DP-1111-02CT | Start Date*: 2021-10-19 | |||||||||||
Sponsor Name:ITM Solucin GmbH | |||||||||||||
Full Title: A Prospective, Randomized, Controlled, Open-label, Multicenter Trial to Evaluate Efficacy, Safety and Patient- reported Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium (177Lu... | |||||||||||||
Medical condition: Well-differentiated Aggressive Grade2 and Grade 3, Somatostatin receptor-positive (SSTR+), Neuroendocrine Tumors of GastroEnteric or Pancreatic Origin (GEP-NET) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Ongoing) ES (Ongoing) IT (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002205-26 | Sponsor Protocol Number: FNUSA-2020-01 | Start Date*: 2020-06-18 | ||||||||||||||||
Sponsor Name:Fakultní nemocnice u sv. Anny v Brně | ||||||||||||||||||
Full Title: [68Ga] -SomaKIT-TOC PET / CT in postoperative evaluation of meningioma residues in the cranial base area | ||||||||||||||||||
Medical condition: evaluation of meningioma residues in the cranial base area | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002218-15 | Sponsor Protocol Number: START-01 | Start Date*: 2022-01-20 | |||||||||||
Sponsor Name:Region Skåne | |||||||||||||
Full Title: Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors - An open-label, multicenter, randomized controlled trial comparing safety and efficacy of personalized vs non-personalized radionuc... | |||||||||||||
Medical condition: Patients with SSTR+, advanced, progressive NET Grade 1-3 of any origin for whom Peptide-receptor radionuclide therapy, PRRT, is considered the most appropriate treatment option in relation to other... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.